This 1 Pot Stock Is Recession-Proof

Fire & Flower Holdings Corp. (TSX:FAF) is the only independent cannabis retailer on the TSX. Is it time you invest?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

Yes, you read the title correctly, and no, I am not trying to pull your leg. This cannabis stock is truly that good.

I know what you’re thinking: How can a stock possibly be recession-proof?

To answer this question, let me ask you a question: If you buy something on sale, are you still getting a good deal if the sale is steeper the next day?

For some of you, buying an item and not paying the full price is good enough, but we are only human, and humans are greedy, so most of you would say you would prefer the steeper sale.

Truth be told, this stock is meant for greedy investors — the ones that won’t buy an item unless it is on the top-shelf of the clearance rack.

The stock I’m referring to is Fire & Flower (TSX:FAF) which is an independent cannabis retailer specializing in marijuana and marijuana-related accessories. Based on an investment from Couche-Tard, the stock’s implicit value is $2.16, which means it is currently undervalued by 64%! That’s one heck of a sale.

Couche-Tard investment

A couple of weeks ago, I published an article raving about Fire & Flower. It turns out that I’m not the only entity interested in this company, as Couche-Tard recently made a $26 million investment for 9.9% equity in the company.

The details of the transaction include an option to invest an additional $380 million in growth capital for Fire & Flowers potential global expansion. In addition to this, Couche-Tard will have an option to purchase warrants which represent up to 50.1% of Fire & Flower’s equity.

Couche-Tard operates over 16,000 convenience stores worldwide, which means its expansion experience is priceless to Fire & Flower. The transaction also involves Fire & Flower moving from the TSX Venture Exchange to the Toronto Stock Exchange, which gives it access to more equity from investors.

This upgrade also improves Fire & Flower’s status on the stock market, as many financial institutions are prohibited from investing in stocks that don’t meet certain standards. This is definitely a step in the right direction.

Plans to expand  

Fire & Flower has an aggressive expansion strategy with its 12-18-month outlook as follows: five to eight stores in British Columbia, 30-70 stores in Alberta, five to 15 stores in Saskatchewan, five to 15 stores in Manitoba, and 10-40 stores in Ontario.

On July 10, 2019, the company announced it has received its 23rd licence to operate a cannabis retail store. The licence was issued from the Alberta Gaming, Liquor, and Cannabis Commission (AGLC).

Investors should be excited about this, as it indicates that the AGLC has confidence in Fire & Flower’s ability to operate cannabis stores, which makes it favourable to receive additional licences in the future both from AGLC and commissions in other provinces and territories.

Summary

I seriously could not believe my eyes when I researched this stock. The reason why the true value of the stock is so different from the current price is because most investors have not caught on.

For those of you who are more experienced investors, you will know that a stock’s volatility is proportionate to its popularity. This stock is currently not in the spotlight, which means that institutional investors have not started manipulating the price yet.

If I were you, I would get in before the stock doubles!

If you liked this article click, the link below for exclusive insight.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chen Liu owns shares of FIRE & FLOWER HOLDINGS CORP. Couche-Tard is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »